Copyright Reports & Markets. All rights reserved.

Global Computational Medicine and Drug Discovery Software Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Computational Medicine and Drug Discovery Software Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Database
      • 1.4.3 Software
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Computational Medicine and Drug Discovery Software Market Share by Application (2014-2025)
      • 1.5.2 Computational Physiological Medicine
      • 1.5.3 Drug Discovery And Development
      • 1.5.4 Medical Imaging
      • 1.5.5 Disease Modeling
      • 1.5.6 Predictive Analysis Of Drug Targets
      • 1.5.7 Cellular Simulation
      • 1.5.8 Simulation Software
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Computational Medicine and Drug Discovery Software Market Size
    • 2.2 Computational Medicine and Drug Discovery Software Growth Trends by Regions
      • 2.2.1 Computational Medicine and Drug Discovery Software Market Size by Regions (2014-2025)
      • 2.2.2 Computational Medicine and Drug Discovery Software Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Computational Medicine and Drug Discovery Software Market Size by Manufacturers
      • 3.1.1 Global Computational Medicine and Drug Discovery Software Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Computational Medicine and Drug Discovery Software Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Computational Medicine and Drug Discovery Software Market Concentration Ratio (CR5 and HHI)
    • 3.2 Computational Medicine and Drug Discovery Software Key Players Head office and Area Served
    • 3.3 Key Players Computational Medicine and Drug Discovery Software Product/Solution/Service
    • 3.4 Date of Enter into Computational Medicine and Drug Discovery Software Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Computational Medicine and Drug Discovery Software Market Size by Type (2014-2019)
    • 4.2 Global Computational Medicine and Drug Discovery Software Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Computational Medicine and Drug Discovery Software Market Size (2014-2019)
    • 5.2 Computational Medicine and Drug Discovery Software Key Players in United States
    • 5.3 United States Computational Medicine and Drug Discovery Software Market Size by Type
    • 5.4 United States Computational Medicine and Drug Discovery Software Market Size by Application

    6 Europe

    • 6.1 Europe Computational Medicine and Drug Discovery Software Market Size (2014-2019)
    • 6.2 Computational Medicine and Drug Discovery Software Key Players in Europe
    • 6.3 Europe Computational Medicine and Drug Discovery Software Market Size by Type
    • 6.4 Europe Computational Medicine and Drug Discovery Software Market Size by Application

    7 China

    • 7.1 China Computational Medicine and Drug Discovery Software Market Size (2014-2019)
    • 7.2 Computational Medicine and Drug Discovery Software Key Players in China
    • 7.3 China Computational Medicine and Drug Discovery Software Market Size by Type
    • 7.4 China Computational Medicine and Drug Discovery Software Market Size by Application

    8 Japan

    • 8.1 Japan Computational Medicine and Drug Discovery Software Market Size (2014-2019)
    • 8.2 Computational Medicine and Drug Discovery Software Key Players in Japan
    • 8.3 Japan Computational Medicine and Drug Discovery Software Market Size by Type
    • 8.4 Japan Computational Medicine and Drug Discovery Software Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Computational Medicine and Drug Discovery Software Market Size (2014-2019)
    • 9.2 Computational Medicine and Drug Discovery Software Key Players in Southeast Asia
    • 9.3 Southeast Asia Computational Medicine and Drug Discovery Software Market Size by Type
    • 9.4 Southeast Asia Computational Medicine and Drug Discovery Software Market Size by Application

    10 India

    • 10.1 India Computational Medicine and Drug Discovery Software Market Size (2014-2019)
    • 10.2 Computational Medicine and Drug Discovery Software Key Players in India
    • 10.3 India Computational Medicine and Drug Discovery Software Market Size by Type
    • 10.4 India Computational Medicine and Drug Discovery Software Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Computational Medicine and Drug Discovery Software Market Size (2014-2019)
    • 11.2 Computational Medicine and Drug Discovery Software Key Players in Central & South America
    • 11.3 Central & South America Computational Medicine and Drug Discovery Software Market Size by Type
    • 11.4 Central & South America Computational Medicine and Drug Discovery Software Market Size by Application

    12 International Players Profiles

    • 12.1 Entelos
      • 12.1.1 Entelos Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Computational Medicine and Drug Discovery Software Introduction
      • 12.1.4 Entelos Revenue in Computational Medicine and Drug Discovery Software Business (2014-2019)
      • 12.1.5 Entelos Recent Development
    • 12.2 Genedata
      • 12.2.1 Genedata Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Computational Medicine and Drug Discovery Software Introduction
      • 12.2.4 Genedata Revenue in Computational Medicine and Drug Discovery Software Business (2014-2019)
      • 12.2.5 Genedata Recent Development
    • 12.3 Crown Bioscience
      • 12.3.1 Crown Bioscience Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Computational Medicine and Drug Discovery Software Introduction
      • 12.3.4 Crown Bioscience Revenue in Computational Medicine and Drug Discovery Software Business (2014-2019)
      • 12.3.5 Crown Bioscience Recent Development
    • 12.4 Biognos Ab
      • 12.4.1 Biognos Ab Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Computational Medicine and Drug Discovery Software Introduction
      • 12.4.4 Biognos Ab Revenue in Computational Medicine and Drug Discovery Software Business (2014-2019)
      • 12.4.5 Biognos Ab Recent Development
    • 12.5 Chemical Computing Group
      • 12.5.1 Chemical Computing Group Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Computational Medicine and Drug Discovery Software Introduction
      • 12.5.4 Chemical Computing Group Revenue in Computational Medicine and Drug Discovery Software Business (2014-2019)
      • 12.5.5 Chemical Computing Group Recent Development
    • 12.6 Leadscope
      • 12.6.1 Leadscope Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Computational Medicine and Drug Discovery Software Introduction
      • 12.6.4 Leadscope Revenue in Computational Medicine and Drug Discovery Software Business (2014-2019)
      • 12.6.5 Leadscope Recent Development
    • 12.7 Nimbus Therapeutics
      • 12.7.1 Nimbus Therapeutics Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Computational Medicine and Drug Discovery Software Introduction
      • 12.7.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Discovery Software Business (2014-2019)
      • 12.7.5 Nimbus Therapeutics Recent Development
    • 12.8 Rhenovia Pharma Limited
      • 12.8.1 Rhenovia Pharma Limited Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Computational Medicine and Drug Discovery Software Introduction
      • 12.8.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Discovery Software Business (2014-2019)
      • 12.8.5 Rhenovia Pharma Limited Recent Development
    • 12.9 Schrodinger
      • 12.9.1 Schrodinger Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Computational Medicine and Drug Discovery Software Introduction
      • 12.9.4 Schrodinger Revenue in Computational Medicine and Drug Discovery Software Business (2014-2019)
      • 12.9.5 Schrodinger Recent Development
    • 12.10 Compugen
      • 12.10.1 Compugen Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Computational Medicine and Drug Discovery Software Introduction
      • 12.10.4 Compugen Revenue in Computational Medicine and Drug Discovery Software Business (2014-2019)
      • 12.10.5 Compugen Recent Development
    • 12.11 Dassault Systemes

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models.
      The computational medicine and drug discovery market is poised to grow at a CAGR of 5.1% to reach $6.78 Billion by 2020.
      In 2018, the global Computational Medicine and Drug Discovery Software market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Computational Medicine and Drug Discovery Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computational Medicine and Drug Discovery Software development in United States, Europe and China.

      The key players covered in this study
      Entelos
      Genedata
      Crown Bioscience
      Biognos Ab
      Chemical Computing Group
      Leadscope
      Nimbus Therapeutics
      Rhenovia Pharma Limited
      Schrodinger
      Compugen
      Dassault Systemes

      Market segment by Type, the product can be split into
      Database
      Software
      Others

      Market segment by Application, split into
      Computational Physiological Medicine
      Drug Discovery And Development
      Medical Imaging
      Disease Modeling
      Predictive Analysis Of Drug Targets
      Cellular Simulation
      Simulation Software

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Computational Medicine and Drug Discovery Software status, future forecast, growth opportunity, key market and key players.
      To present the Computational Medicine and Drug Discovery Software development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Computational Medicine and Drug Discovery Software are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now